Literature DB >> 19055324

Molecular cloning and characterization of a candidate human growth-related and time-keeping constitutive cell surface hydroquinone (NADH) oxidase.

Ziying Jiang1, Nina M Gorenstein, Dorothy M Morré, D James Morré.   

Abstract

ENOX (ECTO-NOX) proteins are growth-related cell surface proteins that catalyze both hydroquinone or NADH oxidation and protein disulfide-thiol interchange and exhibit both prion-like and time-keeping (clock) properties. The two enzymatic activities they catalyze alternate to generate a regular period of 24 min in length. Here we report the cloning, expression, and characterization of a human candidate constitutive ENOX (CNOX or ENOX1) protein. The gene encoding this 643 amino acid long protein is located on chromosome 13 (13q 14.11). Functional motifs previously identified by site-directed mutagenesis in a cancer-associated ENOX (tNOX or ENOX2) as adenine nucleotide or copper binding along with essential cysteines are present, but the drug-binding motif (EEMTE) sequence of ENOX2 is absent. The activities of the recombinant protein expressed in Escherichia coli were not affected by capsaicin, EGCg, and other ENOX2-inhibiting substances. The purified recombinant protein bound ca. 2 mol of copper/mol of protein. Bound copper was necessary for activity. H260 and H579 were required for copper binding as confirmed by site-directed mutagenesis, loss of copper-binding capacity, and resultant loss of enzymatic activity. Addition of melatonin phased the 24 min period such that the next complete period began exactly 24 min after the melatonin addition as appears to be characteristic of ENOX1 activities in general. Oxidative activity was exhibited with both NAD(P)H and reduced coenzyme Q as substrate. Concentrated solutions of the purified candidate ENOX1 protein irreversibly formed insoluble aggregates, devoid of enzymatic activity, resembling amyloid.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19055324     DOI: 10.1021/bi801073p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Essential role of copper in the activity and regular periodicity of a recombinant, tumor-associated, cell surface, growth-related and time-keeping hydroquinone (NADH) oxidase with protein disulfide-thiol interchange activity (ENOX2).

Authors:  Xiaoyu Tang; P-J Chueh; Ziying Jiang; Sara Layman; Berdine Martin; Chinpal Kim; Dorothy M Morré; D James Morré
Journal:  J Bioenerg Biomembr       Date:  2010-10-05       Impact factor: 2.945

2.  The novel antiangiogenic VJ115 inhibits the NADH oxidase ENOX1 and cytoskeleton-remodeling proteins.

Authors:  Amudhan Venkateswaran; David B Friedman; Alexandra J Walsh; Melissa C Skala; Soumya Sasi; Girish Rachakonda; Peter A Crooks; Michael L Freeman; Konjeti R Sekhar
Journal:  Invest New Drugs       Date:  2012-10-09       Impact factor: 3.850

3.  Biological aging alters circadian mechanisms in murine adipose tissue depots.

Authors:  Gregory M Sutton; Andrey A Ptitsyn; Z Elizabeth Floyd; Gang Yu; Xiying Wu; Katie Hamel; Forum S Shah; Armand Centanni; Kenneth Eilertsen; Indu Kheterpal; Susan Newman; Claudia Leonardi; Michael A Freitas; Bruce A Bunnell; Jeffrey M Gimble
Journal:  Age (Dordr)       Date:  2012-03-13

Review 4.  Update on a tumor-associated NADH oxidase in gastric cancer cell growth.

Authors:  Hsiao-Ling Cheng; Yi-Hui Lee; Tein-Ming Yuan; Shi-Wen Chen; Pin-Ju Chueh
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

5.  Increased Expression of Ecto-NOX Disulfide-thiol Exchanger 1 (ENOX1) in Diabetic Mice Retina and its Involvement in Diabetic Retinopathy Development.

Authors:  Yu-Chuen Huang; Shih-Ping Liu; Shih-Yin Chen; Jane-Ming Lin; Hui-Ju Lin; Yu-Jie Lei; Yeh-Han Wang; Wan-Ting Huang; Wen-Ling Liao; Fuu-Jen Tsai
Journal:  In Vivo       Date:  2019 Nov-Dec       Impact factor: 2.155

6.  Tocotrienol Rich Fraction Supplementation Modulate Brain Hippocampal Gene Expression in APPswe/PS1dE9 Alzheimer's Disease Mouse Model.

Authors:  Wan Nurzulaikha Wan Nasri; Suzana Makpol; Musalmah Mazlan; Ikuo Tooyama; Wan Zurinah Wan Ngah; Hanafi Ahmad Damanhuri
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

7.  Targeting Glioblastoma via Selective Alteration of Mitochondrial Redox State.

Authors:  Akira Sumiyoshi; Sayaka Shibata; Zhivko Zhelev; Thomas Miller; Dessislava Lazarova; Ichio Aoki; Takayuki Obata; Tatsuya Higashi; Rumiana Bakalova
Journal:  Cancers (Basel)       Date:  2022-01-19       Impact factor: 6.639

8.  Clinical Significance of Serum Kallistatin and ENOX1 Levels in Patients with Coronary Heart Disease.

Authors:  Rui Zhang; Zhenjun Ji; Junyan Cai; Yongjun Li; Genshan Ma
Journal:  Med Princ Pract       Date:  2020-07-24       Impact factor: 1.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.